Ocular therapy using Glucocorticoid Derivatives selectively penetrating posterior segment tissues

Details for Australian Patent Application No. 2006304416 (hide)

Owner Allergan Inc.

Inventors Edelman, Jeffrey L.; Harrison, Kelly M.

Agent Davies Collison Cave

Pub. Number AU-A-2006304416

PCT Pub. Number WO2007/047607

Priority 60/728,209 18.10.05 US

Filing date 17 October 2006

Wipo publication date 26 April 2007

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2007/047607 Priority application(s): WO2007/047607

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304418-Inhibition of placenta growth factor (PIGF) medicated metastasis and/or angiogenesis

2006304414-Products and processes for managing life instruments